{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:10:05Z","timestamp":1772172605890,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1007688","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000}}],"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R00-CA194163"],"award-info":[{"award-number":["R00-CA194163"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35-GM133404"],"award-info":[{"award-number":["R35-GM133404"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA046592"],"award-info":[{"award-number":["P30-CA046592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32-CA009676"],"award-info":[{"award-number":["T32-CA009676"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014042","name":"DOD Peer Reviewed Cancer Research Program","doi-asserted-by":"publisher","award":["W81XWH1810427"],"award-info":[{"award-number":["W81XWH1810427"]}],"id":[{"id":"10.13039\/100014042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","award":["V2017-011"],"award-info":[{"award-number":["V2017-011"]}],"id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001287","name":"Elsa U. Pardee Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1007688","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:59:28Z","timestamp":1582293568000},"page":"e1007688","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Phenotype-based probabilistic analysis of heterogeneous responses to cancer drugs and their combination efficacy"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7981-7333","authenticated-orcid":true,"given":"Natacha","family":"Comandante-Lou","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8757-8013","authenticated-orcid":true,"given":"Mehwish","family":"Khaliq","sequence":"additional","affiliation":[]},{"given":"Divya","family":"Venkat","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7033-8977","authenticated-orcid":true,"given":"Mohan","family":"Manikkam","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0917-3525","authenticated-orcid":true,"given":"Mohammad","family":"Fallahi-Sichani","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"pcbi.1007688.ref001","first-page":"331","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"WR Greco","year":"1995","journal-title":"Pharmacol Rev"},{"key":"pcbi.1007688.ref002","first-page":"93","article-title":"What is synergy?","volume":"41","author":"MC Berenbaum","year":"1989","journal-title":"Pharmacol Rev"},{"key":"pcbi.1007688.ref003","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: current methodological landscape","volume":"3","author":"J Foucquier","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"pcbi.1007688.ref004","doi-asserted-by":"crossref","first-page":"E237","DOI":"10.1152\/ajpendo.00308.2012","article-title":"Understanding synergy","volume":"304","author":"N Geary","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"pcbi.1007688.ref005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.3853","article-title":"Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs","volume":"13","author":"M Hafner","year":"2016","journal-title":"Nat Methods"},{"key":"pcbi.1007688.ref006","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nmeth.3852","article-title":"An unbiased metric of antiproliferative drug effect in vitro","volume":"13","author":"LA Harris","year":"2016","journal-title":"Nat Methods"},{"key":"pcbi.1007688.ref007","first-page":"38","article-title":"Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells","author":"C Margue","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"pcbi.1007688.ref008","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.1254721","article-title":"Patient-derived models of acquired resistance can identify effective drug combinations for cancer","volume":"346","author":"AS Crystal","year":"2014","journal-title":"Science"},{"key":"pcbi.1007688.ref009","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/onc.2011.309","article-title":"Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma","volume":"31","author":"J de Lange","year":"2012","journal-title":"Oncogene"},{"key":"pcbi.1007688.ref010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cels.2019.01.003","article-title":"Quantifying Drug Combination Synergy along Potency and Efficacy Axes","volume":"8","author":"CT Meyer","year":"2019","journal-title":"Cell Syst"},{"key":"pcbi.1007688.ref011","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for Drug Synergy in Complex Dose\u2013Response Landscapes Using an Interaction Potency Model","volume":"13","author":"B Yadav","year":"2015","journal-title":"Comput Struct Biotechnol J"},{"key":"pcbi.1007688.ref012","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/MMBR.20.4.243-258.1956","article-title":"The calculation of microbial assays","volume":"20","author":"CI Bliss","year":"1956","journal-title":"Bacteriol Rev"},{"key":"pcbi.1007688.ref013","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"TC Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"pcbi.1007688.ref014","first-page":"313","article-title":"Effect of combinations: Mathematical basis of problem","volume":"114","author":"S Loewe","year":"1926","journal-title":"Arch Exp Pathol Pharmacol"},{"key":"pcbi.1007688.ref015","volume-title":"Pharmacology","author":"JH Gaddum","year":"1940"},{"key":"pcbi.1007688.ref016","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"CI Bliss","year":"1939","journal-title":"Ann Appl Biol"},{"key":"pcbi.1007688.ref017","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nchembio.1337","article-title":"Metrics other than potency reveal systematic variation in responses to cancer drugs","volume":"9","author":"M Fallahi-Sichani","year":"2013","journal-title":"Nat Chem Biol"},{"key":"pcbi.1007688.ref018","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/clpt.2010.96","article-title":"Dissecting variability in responses to cancer chemotherapy through systems pharmacology","volume":"88","author":"R Yang","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"pcbi.1007688.ref019","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1200\/JCO.2007.10.8332","article-title":"Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity","volume":"26","author":"NS Azad","year":"2008","journal-title":"J Clin Oncol"},{"key":"pcbi.1007688.ref020","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1200\/jco.2008.26.15_suppl.5011","article-title":"Updated results of phase I trial of sorafenib (S) and bevacizumab (B) in patients with metastatic renal cell cancer (mRCC)","volume":"26","author":"JA Sosman","year":"2008","journal-title":"J Clin Oncol"},{"key":"pcbi.1007688.ref021","doi-asserted-by":"crossref","first-page":"905","DOI":"10.15252\/msb.20166796","article-title":"Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated state","volume":"13","author":"M Fallahi-Sichani","year":"2017","journal-title":"Mol Syst Biol"},{"key":"pcbi.1007688.ref022","doi-asserted-by":"crossref","first-page":"797","DOI":"10.15252\/msb.20145877","article-title":"Systematic analysis of BRAF(V600E) melanomas reveals a role for JNK\/c-Jun pathway in adaptive resistance to drug-induced apoptosis","volume":"11","author":"M Fallahi-Sichani","year":"2015","journal-title":"Mol Syst Biol"},{"key":"pcbi.1007688.ref023","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nchembio.1365","article-title":"Drug discovery: Rethinking cellular drug response","volume":"9","author":"JL Jenkins","year":"2013","journal-title":"Nat Chem Biol"},{"key":"pcbi.1007688.ref024","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ccr.2008.07.002","article-title":"Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs","volume":"14","author":"KE Gascoigne","year":"2008","journal-title":"Cancer Cell"},{"key":"pcbi.1007688.ref025","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1126\/science.1160165","article-title":"Dynamic proteomics of individual cancer cells in response to a drug","volume":"322","author":"AA Cohen","year":"2008","journal-title":"Science"},{"key":"pcbi.1007688.ref026","first-page":"563","article-title":"In vivo determination of the fractional kill of human tumor cells by chemotherapeutic agents","volume":"56","author":"MC Berenbaum","year":"1972","journal-title":"Cancer Chemother Rep"},{"key":"pcbi.1007688.ref027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.06.014","article-title":"The role of phenotypic plasticity in the escape of cancer cells from targeted therapy","volume":"122","author":"MF Emmons","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"pcbi.1007688.ref028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coisb.2018.03.003","article-title":"Drug persistence\u2014from antibiotics to cancer therapies","volume":"10","author":"K Kochanowski","year":"2018","journal-title":"Curr Opin Syst Biol"},{"key":"pcbi.1007688.ref029","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"MJ Hangauer","year":"2017","journal-title":"Nature"},{"key":"pcbi.1007688.ref030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature22794","article-title":"Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance","volume":"546","author":"SM Shaffer","year":"2017","journal-title":"Nature"},{"key":"pcbi.1007688.ref031","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"SV Sharma","year":"2010","journal-title":"Cell"},{"key":"pcbi.1007688.ref032","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nm.4091","article-title":"A framework for understanding and targeting residual disease in oncogene-driven solid cancers","volume":"22","author":"TG Bivona","year":"2016","journal-title":"Nat Med"},{"key":"pcbi.1007688.ref033","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2012.02.028","article-title":"Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency","volume":"21","author":"G Wei","year":"2012","journal-title":"Cancer Cell"},{"key":"pcbi.1007688.ref034","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1038\/ncomms10690","article-title":"Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells","volume":"7","author":"M Ramirez","year":"2016","journal-title":"Nat Commun"},{"key":"pcbi.1007688.ref035","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","article-title":"Toward Minimal Residual Disease-Directed Therapy in Melanoma","volume":"174","author":"F Rambow","year":"2018","journal-title":"Cell"},{"key":"pcbi.1007688.ref036","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nm.4058","article-title":"The cellular origins of drug resistance in cancer","volume":"22","author":"GR Oxnard","year":"2016","journal-title":"Nat Med"},{"key":"pcbi.1007688.ref037","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nmeth.2138","article-title":"Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data","volume":"9","author":"DR Tyson","year":"2012","journal-title":"Nat Methods"},{"key":"pcbi.1007688.ref038","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.cell.2017.11.009","article-title":"Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy","volume":"171","author":"AC Palmer","year":"2017","journal-title":"Cell"},{"key":"pcbi.1007688.ref039","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2007.12.033","article-title":"Visualizing spatiotemporal dynamics of multicellular cell-cycle progression","volume":"132","author":"A Sakaue-Sawano","year":"2008","journal-title":"Cell"},{"key":"pcbi.1007688.ref040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.molcel.2018.06.031","article-title":"Fluctuations in p53 Signaling Allow Escape from Cell-Cycle Arrest","volume":"71","author":"J Reyes","year":"2018","journal-title":"Mol Cell"},{"key":"pcbi.1007688.ref041","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1158\/1535-7163.MCT-08-0431","article-title":"Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas","volume":"7","author":"KSM Smalley","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"pcbi.1007688.ref042","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","article-title":"Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells","volume":"23","author":"A Roesch","year":"2013","journal-title":"Cancer Cell"},{"key":"pcbi.1007688.ref043","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1158\/0008-5472.CAN-19-0040","article-title":"HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy","volume":"79","author":"MF Emmons","year":"2019","journal-title":"Cancer Res"},{"key":"pcbi.1007688.ref044","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1158\/2159-8290.CD-18-0879","article-title":"MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas","volume":"9","author":"O Maertens","year":"2019","journal-title":"Cancer Discov"},{"key":"pcbi.1007688.ref045","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.cell.2018.04.012","article-title":"An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential","volume":"173","author":"L Wang","year":"2018","journal-title":"Cell"},{"key":"pcbi.1007688.ref046","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708446","article-title":"Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma","volume":"10","author":"IM Echevarr\u00eda-Vargas","year":"2018","journal-title":"EMBO Mol Med"},{"key":"pcbi.1007688.ref047","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ccell.2018.01.002","article-title":"Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma","volume":"33","author":"Y Yu","year":"2018","journal-title":"Cancer Cell"},{"key":"pcbi.1007688.ref048","article-title":"Kinetic Inference Resolves Epigenetic Mechanism of Drug Resistance in Melanoma","author":"Y Su","year":"2019","journal-title":"Cancer Biology"},{"key":"pcbi.1007688.ref049","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101480","article-title":"Epigenetic Mechanisms of Escape from BRAF Oncogene Dependency","volume":"11","author":"M Khaliq","year":"2019","journal-title":"Cancers"},{"key":"pcbi.1007688.ref050","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"J Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"pcbi.1007688.ref051","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1073\/pnas.0808843106","article-title":"Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning","volume":"106","author":"TR Jones","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"pcbi.1007688.ref052","unstructured":"Tinevez JY. TrackMate: An open and extensible platform for single-particle tracking. 2016. http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1046202316303346"},{"key":"pcbi.1007688.ref053","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fphar.2017.00158","article-title":"An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines","volume":"8","author":"KR Roell","year":"2017","journal-title":"Front Pharmacol"},{"key":"pcbi.1007688.ref054","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12551-013-0122-2","article-title":"Stochastic chemical kinetics: A review of the modelling and simulation approaches","volume":"5","author":"P Lecca","year":"2013","journal-title":"Biophys Rev"},{"key":"pcbi.1007688.ref055","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1371\/journal.pbio.0060299","article-title":"Modeling a snap-action, variable-delay switch controlling extrinsic cell death","volume":"6","author":"JG Albeck","year":"2008","journal-title":"PLoS Biol"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007688","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T13:45:24Z","timestamp":1583329524000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007688"}},"subtitle":[],"editor":[{"given":"Lingchong","family":"You","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007688","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/797225","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]}}}